EL7.AI
StocksMediumUpdated•Originally published 3 August 2026•Updated 3 August 2026•
1 min read

US Companies Report Record Q2 2026 Earnings and Raise Full-Year Guidance

Key Facts

1Jazz Pharmaceuticals reported record total revenues of $1.2 billion, up 16% YoY, and raised its 2026 revenue guidance.
2Allison Transmission reported net sales of $1,566 million, up 92% YoY, driven by acquisitions and Defense market momentum.
3Matson, Inc. reported 2Q26 EPS of $4.27 compared to $2.92 in the prior year and raised its full-year outlook.

Amid continued resilience in the US economy and expansion across manufacturing and service sectors, several listed companies reported strong financial results for the second quarter of 2026. Jazz Pharmaceuticals achieved record revenues of $1.2 billion, a 16% year-over-year increase, leading the company to raise its full-year revenue guidance. Similarly, Allison Transmission saw an exceptional 92% surge in net sales to $1.56 billion, driven by defense market momentum and strategic acquisitions, while Matson reported an EPS of $4.27, up from $2.92 in the prior year.

These results reflect optimism across diverse sectors including pharmaceuticals, heavy industrials, and logistics, demonstrating how companies are successfully leveraging acquisitions into tangible top-line growth. According to market data, this robust performance coincides with improvements in broader economic indicators; recent data showed rising consumer confidence in France and Spain, and a drop in Spain's unemployment rate to 9.87%, suggesting a supportive global operating environment for multi-national firms.

Looking ahead, investors are monitoring the sustainability of this growth following the Federal Reserve's decision to hold interest rates at 3.75% as of July 29, 2026.